Comunicados de prensa MHRA — Medicines and Healthcare products Regulatory Agency — Feed RSS y monitoreo en vivo
PPN World sigue el feed RSS de MHRA — Medicines and Healthcare products Regulatory Agency en tiempo real — 15 comunicados indexados en los últimos 30 días, el más reciente llegó hace 6 d. Síguelo con alertas de búsquedas guardadas, resúmenes con IA y búsqueda de texto completo, o conecta la URL RSS de abajo a tu propio lector.
URL del feed RSS de MHRA — Medicines and Healthcare products Regulatory Agency
https://www.gov.uk/search/news-and-communications.atom?organisations%5B%5D=medicines-and-healthcare-products-regulatory-agencySobre este feed
MHRA — Medicines and Healthcare products Regulatory Agency forma parte de los más de 1200 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada bajo «Reino Unido» en nuestro índice por país. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. En los últimos 30 días, MHRA — Medicines and Healthcare products Regulatory Agency ha publicado 15 comunicados, sobre todo los miércoles.
Cómo seguir los comunicados de MHRA — Medicines and Healthcare products Regulatory Agency
- Copia la URL del feed RSS de MHRA — Medicines and Healthcare products Regulatory Agency que aparece arriba.
- Pégala en cualquier lector RSS (Feedly, Inoreader, NetNewsWire…) para recibir el feed sin procesar.
- O sigue MHRA — Medicines and Healthcare products Regulatory Agency en PPN World para añadir deduplicación, alertas de búsquedas guardadas y resúmenes con IA en los más de 1200 feeds.
Últimos comunicados de MHRA — Medicines and Healthcare products Regulatory Agency
- Thousands of patients to benefit from new daily pill for serious heart condition following co-ordinated MHRA and NICE decisionshace 3 h
Aficamten is recommended by NICE at the same time it was approved by the MHRA, thanks to improvements driven by closer working between the two organisations.
- Pioneering AI health innovations regulatory sandbox launchedhace 4 h
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
- Beat the heat: MHRA urges people to take extra care with medical devices this summerhace 1 d
Simple steps to help keep your essential medical equipment working safely when temperatures rise.
- MHRA clarifies regulatory status of ambient voice technologies used in the NHShace 1 d
The Medicines and Healthcare products Regulatory Agency has published guidance, developed in close partnership with NHS England, clarifying how existing medical device law applies to ambient voice tec…
- No summer shortcut for safe weight losshace 6 d
As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers, and avoid diet changes that could interfere with their medi…
- MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthmahace 9 d
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.
- Hot cars, hot luggage: why where you store your medicines matters this summerhace 13 d
As part of the ‘Summer-proof your health’ campaign, the MHRA is reminding people that heat and poor storage, at home or while travelling, can affect how well some medicines work.
- MHRA delivers record performance as 2025-26 Annual Report and Accounts confirms growing global influencehace 14 d
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and consistent delivery as set out in the agency’s fir…
- Updated warnings for botulinum toxin products following rare cases of botulismhace 14 d
The MHRA is strengthening safety warnings for all botulinum toxin type A products, following reports of rare cases of botulism linked to their use.
- UK-donor plasma given go-ahead for new medicineshace 14 d
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.
- Yellow Cards: bad in football; brilliant in patient safetyhace 20 d
As football fans across the country get behind England, the MHRA wants to keep any Yellow Cards off the pitch – and instead let people know that Yellow Cards can make an important impact in a very dif…
- Heat, travel and late nights: How summer can affect your medicines and how to stay safehace 21 d
The MHRA is urging people to “summer-proof your health” as warmer weather, travel, and changing routines can affect how medicines and medical devices work, with simple steps to help prevent avoidable…
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.